ABCL
Price
$4.47
Change
+$0.57 (+14.62%)
Updated
Jul 18 closing price
Capitalization
1.34B
17 days until earnings call
ATRA
Price
$10.00
Change
+$0.29 (+2.99%)
Updated
Jul 18 closing price
Capitalization
59.61M
Interact to see
Advertisement

ABCL vs ATRA

Header iconABCL vs ATRA Comparison
Open Charts ABCL vs ATRABanner chart's image
AbCellera Biologics
Price$4.47
Change+$0.57 (+14.62%)
Volume$11.6M
Capitalization1.34B
Atara Biotherapeutics
Price$10.00
Change+$0.29 (+2.99%)
Volume$113.05K
Capitalization59.61M
ABCL vs ATRA Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. ATRA commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ATRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ABCL: $4.47 vs. ATRA: $10.00)
Brand notoriety: ABCL and ATRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 200% vs. ATRA: 218%
Market capitalization -- ABCL: $1.34B vs. ATRA: $59.61M
ABCL [@Biotechnology] is valued at $1.34B. ATRA’s [@Biotechnology] market capitalization is $59.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileATRA’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ATRA’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while ATRA’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • ATRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATRA is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +5.18% price change this week, while ATRA (@Biotechnology) price change was +8.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.34B) has a higher market cap than ATRA($59.6M). ABCL YTD gains are higher at: 52.560 vs. ATRA (-24.869). ATRA has higher annual earnings (EBITDA): -5.74M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. ATRA (13.8M). ATRA has less debt than ABCL: ATRA (40.6M) vs ABCL (67.8M). ATRA has higher revenues than ABCL: ATRA (200M) vs ABCL (23.1M).
ABCLATRAABCL / ATRA
Capitalization1.34B59.6M2,243%
EBITDA-211.2M-5.74M3,677%
Gain YTD52.560-24.869-211%
P/E RatioN/AN/A-
Revenue23.1M200M12%
Total Cash605M13.8M4,384%
Total Debt67.8M40.6M167%
FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLATRA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 21 days ago
86%
Bearish Trend 25 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRAEX13.390.04
+0.30%
Meridian Hedged Equity A
LAVSX15.86N/A
N/A
Lord Abbett Fundamental Equity R4
GQHIX13.08-0.01
-0.08%
GQG Partners US Quality Value Fund Ins
EIDIX18.18-0.02
-0.11%
Eaton Vance Global Equity Income I
OGLIX104.13-0.12
-0.12%
Invesco Global R6

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+14.62%
CRSP - ABCL
62%
Loosely correlated
+18.22%
RXRX - ABCL
60%
Loosely correlated
+5.80%
ABSI - ABCL
55%
Loosely correlated
+8.33%
BEAM - ABCL
55%
Loosely correlated
+1.47%
NTLA - ABCL
55%
Loosely correlated
+1.94%
More

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with GRI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+2.99%
GRI - ATRA
40%
Loosely correlated
-6.67%
SLRX - ATRA
39%
Loosely correlated
+0.26%
FULC - ATRA
35%
Loosely correlated
-3.65%
FOLD - ATRA
34%
Loosely correlated
N/A
ABCL - ATRA
33%
Loosely correlated
+14.62%
More